Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies

AIMS: Limited real-world data show that rivaroxaban following dosage criteria from either ROCKET AF [20 mg/day or 15 mg/day if creatinine clearance (CrCl) < 50 mL/min] or J-ROCKET AF (15 mg/day or 10 mg/day if CrCl < 50 mL/min) is associated with comparable risks of thromboembolism and bleedin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi-Hsin, Chan, Chih-Yu, Chen, Shao-Wei, Chao, Tze-Fan, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580379/
https://www.ncbi.nlm.nih.gov/pubmed/37738425
http://dx.doi.org/10.1093/europace/euad288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580379/
https://www.ncbi.nlm.nih.gov/pubmed/37738425
http://dx.doi.org/10.1093/europace/euad288

Ejemplares similares